Ratings OMRON Corporation OTC Markets

Equities

OMRNY

US6821513032

Market Closed - OTC Markets 03:41:51 2024-05-10 pm EDT 5-day change 1st Jan Change
38.02 USD -2.48% Intraday chart for OMRON Corporation +6.45% -18.19%

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • The company is in a robust financial situation considering its net cash and margin position.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
  • The company's earnings growth outlook lacks momentum and is a weakness.
  • With an expected P/E ratio at 164.14 and 70.35 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • The company is highly valued given the cash flows generated by its activity.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
  • For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • The overall consensus opinion of analysts has deteriorated sharply over the past four months.
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

Ratings chart - Surperformance

Sector: Electrical Components & Equipment

1st Jan change Capi. Investor Rating ESG Refinitiv
-18.19% 7.49B -
+10.81% 159B
A
+27.98% 141B
B+
+37.27% 132B
B+
+18.72% 66.09B
A-
+3.58% 39.54B
B
+98.63% 35.71B
C
+5.58% 31.73B
B
-11.88% 31.19B
B
+9.94% 29.1B
A-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW